A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study

COVID-19 is a global pandemic, with over 50 million confirmed cases and 1.2 million deaths as of November 11, 2020. No therapies or vaccines so far are recommended to treat or prevent the new coronavirus. A novel traditional Chinese medicine formula, Taiwan Chingguan Yihau (NRICM101), has been admin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Keng-Chang, Huang, Yi-Chia, Liaw, Chia-Ching, Tsai, Chia-I, Chiou, Chun-Tang, Lin, Chien-Jung, Wei, Wen-Chi, Lin, Sunny Jui-Shan, Tseng, Yu-Hwei, Yeh, Kuo-Ming, Lin, Yi-Ling, Jan, Jia-Tsrong, Liang, Jian-Jong, Liao, Chun-Che, Chiou, Wen-Fei, Kuo, Yao-Haur, Lee, Shen-Ming, Lee, Ming-Yung, Su, Yi-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676327/
https://www.ncbi.nlm.nih.gov/pubmed/33249281
http://dx.doi.org/10.1016/j.biopha.2020.111037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676327/
https://www.ncbi.nlm.nih.gov/pubmed/33249281
http://dx.doi.org/10.1016/j.biopha.2020.111037

Ejemplares similares